Peritoneal Mesothelioma (Drugs)
Peritoneal Mesothelioma is a rare and aggressive form of cancer that affects the lining of the abdomen (peritoneum). Treatment for peritoneal mesothelioma often involves a combination of surgery, chemotherapy, and sometimes radiation therapy. Here are some drugs commonly used or under investigation for peritoneal mesothelioma:
Cisplatin:
Cisplatin is a chemotherapy drug that is frequently used in the treatment of peritoneal mesothelioma. It works by interfering with the DNA in cancer cells, preventing them from dividing and growing.
Carboplatin:
Similar to cisplatin, carboplatin is another platinum-based chemotherapy drug used to treat peritoneal mesothelioma. It has a different side effect profile and may be an alternative for some patients.
Pemetrexed (Alimta):
Pemetrexed is a chemotherapy drug often used in combination with cisplatin for the treatment of mesothelioma. It works by disrupting the folate-dependent metabolic processes necessary for cancer cell survival.
Bevacizumab (Avastin):
Bevacizumab is a targeted therapy that inhibits the growth of blood vessels within tumors. It is sometimes used in combination with chemotherapy for peritoneal mesothelioma.